Halozyme Therapeutics shares owned by Silvercrest Asset Management Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Silvercrest Asset Management Group
from 13F filings
Historical chart of Silvercrest Asset Management Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Silvercrest Asset Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $24M | 633k | 38.20 |
| 2023-06-30 | $19M | 516k | 36.07 |
| 2023-03-31 | $13M | 341k | 38.19 |
| 2022-12-31 | $24M | 413k | 56.90 |
| 2022-09-30 | $17M | 439k | 39.54 |
| 2022-06-30 | $17M | 384k | 44.00 |
| 2022-03-31 | $12M | 292k | 39.88 |
| 2021-12-31 | $352k | 8.8k | 40.19 |
| 2021-09-30 | $320k | 7.9k | 40.62 |
| 2021-06-30 | $316k | 7.0k | 45.40 |
| 2021-03-31 | $284k | 6.8k | 41.63 |
| 2020-12-31 | $282k | 6.6k | 42.72 |
More positions owned by Silvercrest Asset Management Group
Home Depot (HD)
View all positions for Silvercrest Asset Management Group